{
  "ptid_time": "072_S_2116_2012-11-08",
  "img_path": "/data/qiuhui/data/adni/images/072_S_2116/2012-11-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 60,094 mm³, 100.1% above the reference mean. With a Z-score of 2.38 (99.1th percentile), this represents significant enlargement; whole brain volume measures 1,065,340 mm³, 6.1% below the reference mean. With a Z-score of -0.86 (19.4th percentile), this represents normal volume ; entorhinal cortex volume measures 3,615 mm³, 15.2% below the reference mean. With a Z-score of -1.05 (14.6th percentile), this represents mild atrophy; fusiform gyrus volume measures 21,471 mm³, 7.8% above the reference mean. With a Z-score of 0.65 (74.3th percentile), this represents normal volume ; middle temporal gyrus volume measures 22,447 mm³, 0.2% above the reference mean. With a Z-score of 0.01 (50.5th percentile), this represents normal volume . ",
  "text_data": "Age is 63.6 years. Gender is Male. Education: 17 years. MMSE: 30.0. MoCA: 23.0. Logical Memory: 11.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.99 SUVR (normal ); Amyloid beta: 1534.00 pg/mL (mild elevated); Total tau: 121.80 pg/mL (mild reduced); Phosphorylated tau: 10.61 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (suggesting possible atrophy) and mild entorhinal cortex atrophy, which are early markers of Alzheimer's pathology. However, cognitive scores are mixed (MMSE normal, MoCA mildly impaired), and biomarkers (Aβ mildly elevated, normal AV45) do not strongly support active amyloid deposition.  \n**Diagnosis:** **MCI (Mild Cognitive Impairment)**  \n**Confidence:** **Medium** (due to conflicting biomarker and imaging findings with only mild cognitive impairment)",
  "timestamp": "2025-07-26T09:13:57.325911"
}